Your Partner in
Urology and Oncology


About TerSera™ Canada

We acquire and develop specialty pharmaceutical products with a focus on select therapeutic areas.

Our mission is to market products which truly make a difference for patients.

Our focus is to bring intelligent solutions to prescribers and patients who need better solutions.

We deliver a comprehensive set of programs that go beyond the therapy itself in order to provide improved outcomes for patients.

For more information about TerSera™ Canada, please contact us.




TerSera has offices in the Canada and the United States to serve patients, partners and prescribers across North America.

> See Our Locations

Prescribing Information

Our products make a difference for patients and provide solutions for prescribers. We invite you to view the full prescribing information for our products.

> View Prescribing Information

Business Development

TerSera develops, acquires and licenses innovative products that improve patient outcomes.

> Find Out More

Therapeutic Experience

The TerSera team has significant collective specialty pharmaceutical experience. We have worked with compounds in all phases of pre-clinical and clinical development, as well as lifecycle management and phase IV studies.

TerSera Canada News


February 20, 2017

AstraZeneca announced today that it has entered into an agreement with TerSera Therapeutics LLC (“TerSera”) for the commercial rights to Zoladex (goserelin acetate implant) in the US and Canada. This transaction is expected to close during Q1 of 2017.


Interested in learning more about TerSera Canada?
Please contact us.

TerSera Canada Inc.

2425 Matheson Blvd. East
Suite 872
Mississauga, Ontario
L4W 5K4

(888) 568-8556


For general inquiries, media information, or new business opportunities please complete and submit the contact form below.

* Required information

Name *
Phone Number *
Phone Number